Independent Evaluation of SARS-CoV-2 Antibody Test Performance

In collaboration with the NCI, CDC, and BARDA, the FDA has developed a comprehensive dataset to compare the performance characteristics of different serological tests that were independently evaluated using well-characterized sample panels of positive and negative specimens for SARS-CoV-2 antibodies.

Source link

Author: Admin

Leave a Reply

Your email address will not be published.